Trust Point Inc. Makes New $2.33 Million Investment in Chemed Co. (NYSE:CHE)

Trust Point Inc. acquired a new position in shares of Chemed Co. (NYSE:CHEFree Report) during the 4th quarter, HoldingsChannel reports. The institutional investor acquired 3,976 shares of the company’s stock, valued at approximately $2,325,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. DAVENPORT & Co LLC acquired a new stake in Chemed during the 4th quarter worth about $250,000. Fenimore Asset Management Inc. increased its holdings in shares of Chemed by 0.4% in the 4th quarter. Fenimore Asset Management Inc. now owns 27,202 shares of the company’s stock valued at $15,906,000 after purchasing an additional 115 shares during the period. Chicago Capital LLC acquired a new position in shares of Chemed in the 4th quarter valued at about $1,170,000. Fort Washington Investment Advisors Inc. OH increased its holdings in shares of Chemed by 4.4% in the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 31,138 shares of the company’s stock valued at $18,208,000 after purchasing an additional 1,320 shares during the period. Finally, Pacer Advisors Inc. increased its holdings in shares of Chemed by 46.0% in the 4th quarter. Pacer Advisors Inc. now owns 2,665 shares of the company’s stock valued at $1,558,000 after purchasing an additional 840 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analyst Upgrades and Downgrades

CHE has been the topic of a number of research reports. Oppenheimer upped their target price on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a report on Thursday, February 29th. Royal Bank of Canada increased their price objective on Chemed from $604.00 to $712.00 and gave the stock an “outperform” rating in a report on Monday, March 4th.

Check Out Our Latest Research Report on Chemed

Chemed Stock Down 0.2 %

CHE stock traded down $0.98 during midday trading on Wednesday, hitting $635.84. 13,002 shares of the company traded hands, compared to its average volume of 79,945. Chemed Co. has a twelve month low of $492.84 and a twelve month high of $654.62. The business has a 50 day simple moving average of $616.07 and a 200-day simple moving average of $579.61. The stock has a market capitalization of $9.61 billion, a price-to-earnings ratio of 35.41, a price-to-earnings-growth ratio of 2.57 and a beta of 0.42.

Chemed (NYSE:CHEGet Free Report) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $6.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.25 by $0.35. The business had revenue of $585.90 million for the quarter, compared to the consensus estimate of $586.64 million. Chemed had a net margin of 12.03% and a return on equity of 32.29%. Chemed’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the company posted $5.39 earnings per share. Equities research analysts forecast that Chemed Co. will post 21.99 EPS for the current year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Monday, February 26th were given a $0.40 dividend. The ex-dividend date was Friday, February 23rd. This represents a $1.60 annualized dividend and a yield of 0.25%. Chemed’s dividend payout ratio (DPR) is currently 8.93%.

Insider Buying and Selling

In related news, EVP Spencer S. Lee sold 2,000 shares of the firm’s stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the completion of the transaction, the executive vice president now directly owns 20,760 shares of the company’s stock, valued at $13,320,654. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Chemed news, EVP Spencer S. Lee sold 2,000 shares of Chemed stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the completion of the transaction, the executive vice president now directly owns 20,760 shares of the company’s stock, valued at $13,320,654. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Michael D. Witzeman sold 2,650 shares of Chemed stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $643.14, for a total value of $1,704,321.00. Following the transaction, the chief financial officer now directly owns 2,882 shares of the company’s stock, valued at $1,853,529.48. The disclosure for this sale can be found here. Insiders sold a total of 15,808 shares of company stock valued at $10,184,531 over the last ninety days. 3.80% of the stock is owned by company insiders.

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.